KAVAPOINT
For healthcare professionals including physicians, nurses, and pharmacists, alongside general smartphone users seeking basic utility tools.
Snapshot
Who is KAVAPOINT?
Providing specialized medical reference tools and utility applications for healthcare professionals and general users.
Target audience
Portfolio
Free 1Last updated
Flashlight Pro [Multipurpose LED light]
v3.0
12y ago
Publisher DNA
What defines KAVAPOINT?
Publisher DNA
Primary focus
Medical reference and utility applications
Scale
indie
Target audience
Healthcare professionals including physicians, nurses, and pharmacists, alongside general smartphone users seeking basic utility tools.
Signature Patterns
- •Focus on specialized medical reference content for clinical staff
- •Mixed monetization strategy utilizing both paid and free models
- •Long-term maintenance of legacy utility applications
- •Targeting professional niches alongside general-purpose mobile tools
Portfolio momentum
With only one release in the last six months and two out of three apps classified as abandoned, the publisher is currently in a maintenance or legacy phase.
Portfolio
What does KAVAPOINT ship?
Apps
3 apps analysed
Low-friction $0.99 price point lowers entry barrier
- Concise medical pearls provide high-value learning opportunities for busy clinical professionals during short breaks
- Lack of content updates leaves users reading stale information that does not reflect current evidence
Single-market publisher, every app ships only to United States.
Based on 1 of 3 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
1
Positive apps
0
Neutral / mixed
0
Negative apps
65/100
Avg sentiment score
Rivals
Who does KAVAPOINT compete with?
The rivals identified
Nemeses(2)
Both apps target users managing medication, but they diverge between professional reference utility and daily patient adherence tracking. They compete for the same user base seeking medication-related utility on mobile devices.
Dominates the clinical reference space with high-frequency updates and a massive, established user base.
Contenders(1)
Leverages a massive professional network to integrate clinical reference tools with physician communication and career services.
Same space(12)
Full Code targets medical professionals with simulation-based training, complementing the source app's reference database with active clinical practice.
Cute Pill provides a simplified medication tracking interface for patients and families, lacking the professional database depth of the source app.
gesund.de connects patients to local pharmacies for prescription fulfillment, serving as a transactional bridge rather than a medical reference tool.
GoodRx targets prescription affordability through a pharmacy-network model, acting as a transactional utility rather than a medical reference tool.
Targets the nursing education segment with a focus on exam preparation rather than bedside clinical practice.
MDCalc offers bedside decision support for clinicians, acting as a high-frequency professional tool that complements the source app's drug database.
Medil AI combines medication information with adherence tracking, overlapping with the source app's reference database while adding patient-specific management.
mediteo provides a medication adherence tool for daily health tracking, serving as a patient-facing companion rather than a professional reference database.
MyTherapy serves as a digital health journal for chronic patients, focusing on adherence rather than the reference database utility of the source app.
Pillo focuses on medication adherence through persistent alarms, contrasting with the reference-heavy focus of the source app.
TakeYourPills functions as a patient-facing medication organizer, focusing on dose tracking rather than the medical reference database provided by the source app.
Serves the same medical education and reference market but focuses on visual 3D anatomical modeling.
New entrants(2)
Shows high development velocity with ten releases in six months, signaling aggressive feature expansion.
Demonstrates strong growth in patient-facing symptom tracking with a high update frequency.
The Analyst's Read
The bottom line on KAVAPOINT
Bottom line
Kavapoint is a legacy publisher that successfully established a foothold in medical reference tools but currently lacks the development velocity to remain competitive in modern app stores. Their portfolio serves as a stable, niche reference library rather than an active growth engine.
Frequently asked questions
How many apps does KAVAPOINT publish?
What kind of apps does KAVAPOINT make?
What is KAVAPOINT's top app?
In how many countries are KAVAPOINT's apps available?
What fed this analysis
- Apps analyzed:
- 3
- With full intel:
- 0
- With overview:
- 3
- Website scraped:
- yes
- Social presence:
- no